Health
WHO launches massive R21 malaria vaccine rollout across Africa and Asia
The World Health Organization has begun a large‑scale distribution of the R21 malaria vaccine in multiple African and Asian nations, aiming to eradicate the disease.
The World Health Organization (WHO) has initiated a broad distribution programme for the new R21 malaria vaccine in several countries across Africa and Asia, marking a concerted effort to eliminate malaria entirely.
The R21 vaccine, which has demonstrated high efficacy in recent clinical trials, is being deployed as part of a coordinated campaign with national health ministries to reach populations most vulnerable to the disease.
The rollout targets high‑transmission regions, prioritising rural and peri‑urban areas where malaria incidence remains highest. Health officials say the initiative will involve mass vaccination drives, community awareness campaigns, and robust monitoring to assess impact.
Experts view the programme as a potential turning point in the global fight against malaria, citing the vaccine’s promising results and the scale of the WHO‑led effort.
If successful, the campaign could pave the way for malaria eradication in the participating nations, setting a precedent for future vaccine‑driven disease‑control strategies.
The R21 vaccine, which has demonstrated high efficacy in recent clinical trials, is being deployed as part of a coordinated campaign with national health ministries to reach populations most vulnerable to the disease.
The rollout targets high‑transmission regions, prioritising rural and peri‑urban areas where malaria incidence remains highest. Health officials say the initiative will involve mass vaccination drives, community awareness campaigns, and robust monitoring to assess impact.
Experts view the programme as a potential turning point in the global fight against malaria, citing the vaccine’s promising results and the scale of the WHO‑led effort.
If successful, the campaign could pave the way for malaria eradication in the participating nations, setting a precedent for future vaccine‑driven disease‑control strategies.